The scientific advisory group on Covid immunisation has deferred “any decision on additional dose” in the absence of consensus on whether there is a need to administer a ‘booster’ to those at high risk of infection or severe illness caused by the coronavirus. “No recommendation has been made by the NTAGI yet,” a senior official told TOI.
from Times of India https://ift.tt/3lHgLAF
https://ift.tt/eA8V8J The scientific advisory group on Covid immunisation has deferred “any decision on additional dose” in the absence of consensus on whether there is a need to administer a ‘booster’ to those at high risk of infection or severe illness caused by the coronavirus. “No recommendation has been made by the NTAGI yet,” a senior official told TOI.
Subscribe to:
Post Comments
(
Atom
)
0 Comments :
Post a Comment
Please do not post the SPAM comment.